APFED Celebrates 18th National Eosinophil Awareness Week with New Awareness Initiatives

ATLANTA - Rezul -- National Eosinophil Awareness Week (NEAW) returns May 18–24, 2025, marking 18 years of progress and public engagement initiatives led by the American Partnership for Eosinophilic Disorders (APFED).

Eosinophils (pronounced ee-oh-sin-oh-fills) are a type of white blood cell that plays an important role in the body's immune defense. However, when present in excessive numbers, eosinophils can cause chronic inflammation and tissue damage—a hallmark of eosinophil-associated diseases. These conditions, which can affect the gastrointestinal tract, lungs, skin, and other organs, impact both children and adults and are often misunderstood or misdiagnosed.

Since its inception, NEAW has provided a vital platform to raise awareness among the public and healthcare professionals, with the goal of promoting earlier diagnoses and improving patient outcomes.

To commemorate this year's observance, APFED will launch a series of initiatives designed to raise awareness and support for patients and their families. Activities include:

• Distribution of free educational resources to help individuals and organizations share accurate, accessible information
• A social media campaign highlighting signs and symptoms of eosinophil-associated diseases, encouraging timely medical attention
• Coordinated magenta lightings of landmarks, bridges, and buildings across the U.S. to visually amplify awareness

APFED will also host its 2nd Annual Virtual Walk for HOPE, a community-driven fundraiser supporting research into eosinophil-associated diseases. Participants are invited to walk, run, bike, or hike in their local areas to help advance understanding and improve outcomes.

More on Rezul News

• Pikmykid Launches $100,000 School Safety Grant Giveaway to Support K–12 Schools Across the U.S
• Slotozilla Data Report: Unveiling 2024's Gaming Statistics
• BK Flooring Releases Their Top Reasons to Upgrade Kitchen Tile Flooring in 2025
• The OpenSSL Corporation and the OpenSSL Foundation Certify Results of Technical Advisory Committee Elections
• ROME-ANTICS Unleashed: A Music Video by Sidow Sobrino Transforms Rome into a Living Stage

Additionally, two global observances will take place during the same week:

• World Eosinophilic Diseases Day (May 18) – A global initiative to educate, advocate, and drive progress for all eosinophil-associated conditions
• The inaugural World EoE Day (May 22) – A new awareness day focused on eosinophilic esophagitis (EoE), a chronic immune-mediated condition where eosinophils accumulate in the esophagus, causing inflammation and difficulty swallowing

"National Eosinophil Awareness Week is a time to educate and bring attention to eosinophil-associated diseases among the public and medical communities," said APFED Executive Director Mary Jo Strobel. "When awareness increases, the diagnostic journey shortens, care becomes more effective, and the entire community is better supported. Our goal is to make daily life better for those affected."

APFED's celebration of this year's National Eosinophil Awareness Week is supported by AstraZeneca, Neocate®, Sanofi, Regeneron, and Takeda.​

For more information about NEAW activities, resources, a calendar of special lightings, and ways to get involved, visit apfed.org/NEAW (https://apfed.org/events/national-eosinophil-awareness-week/).​

More on Rezul News

• Home Run Pest & Termite Control Recommends Annual Termite Inspections to Prevent Costly Damage in North Texas Homes
• Mother's Day Wake-Up Call for Maternal Health: New Initiative Demands Better Postpartum Support
• Q1 2025 | Houston Office Market Report
• Southbox Entertainment, FinTech Pioneer & Entrepreneur Jon Gosier Join Psychological Thriller The Dutchman as Financing Partner
• SlotCycle Joins Association of Gaming Equipment Manufacturers (AGEM) to Advance Sustainable Gaming Solutions

About American Partnership for Eosinophilic Disorders (APFED)

Founded in 2001, the American Partnership for Eosinophilic Disorders (APFED) (http://apfed.org/) is a 501(c)(3) nonprofit organization that assists and supports patients and families affected by eosinophil-associated disorders, by providing education, creating awareness, supporting research, and promoting advocacy. To learn more, visit apfed.org.